+ All Categories
Home > Documents > Immunogenicity of Biopharmaceuticals Final ABIRISK Open...

Immunogenicity of Biopharmaceuticals Final ABIRISK Open...

Date post: 04-Aug-2020
Category:
Upload: others
View: 2 times
Download: 0 times
Share this document with a friend
1
Organization and Graphic project by: SYMPOSIUM OVERVIEW In Autumn 2017, The European Immunogenicity Platform and the IMI-funded ABIRISK project are organising a joint meeting to cover the field of immunogenicity Presentations by KOL’s in the field from industry and academy and panel discussions will cover a wide range of topics including : novel tools for immunogenicity assessment clinical relevance of immunogenicity standardization of ADA and PK assays risk assessment of emerging complex biologics updates from the regulators (FDA, EMA) predictive biomarkers integrative analysis for statistical prediction of the risk Organised in a high quality hotel in the city center, lunches and coffee breaks included, as well a social event on the second evening Immunogenicity of Biopharmaceuticals LISBON 2017 - NOVEMBER 13 th -16 th Final ABIRISK Open meeting 9 th EIP Open Scientific Symposium Organized under the flag of ABIRISK and the European Immunogenicity Platform (EIP), a central meeting place for European biopharmaceutical companies and scientific experts active in the field of immunogenicity Registration opens 15 June 2017 on the EIP website: www.e-i-p.eu Venue : Altis Hotel Lisbon, Portugal Dates : Monday November 13 - Thursday November 16 2017
Transcript
Page 1: Immunogenicity of Biopharmaceuticals Final ABIRISK Open ...abirisk.eu/documents/Lisbon_Flyer_2017.pdf · well a social event on the second evening Immunogenicity of Biopharmaceuticals

Organization and Graphic project by:

SyMPOSIuM OVERVIEwIn Autumn 2017, The European Immunogenicity Platform and the IMI-funded ABIRISK project are organising a joint meeting to cover the field of immunogenicity

Presentations by KOL’s in the field from industry and academy and panel discussions willcover a wide range of topics including :

novel tools for immunogenicity assessment clinical relevance of immunogenicity standardization of ADA and PK assaysrisk assessment of emerging complex biologicsupdates from the regulators (FDA, EMA)predictive biomarkers integrative analysis for statistical prediction of the risk

Organised in a high quality hotel in the city center, lunches and coffee breaks included, aswell a social event on the second evening

Immunogenicity of Biopharmaceuticals

LISBON 2017 - NOVEMBER 13th-16th

Final ABIRISK Open meeting9th EIP Open Scientific Symposium

Organized under the flag of ABIRISK and the European Immunogenicity Platform (EIP), a central meetingplace for European biopharmaceutical companies and scientific experts active in the field of immunogenicity

Registration opens 15 June 2017 on the EIP website: www.e-i-p.euVenue : Altis Hotel Lisbon, Portugal

Dates : Monday November 13 - Thursday November 16 2017

Recommended